Phase 4 Diabetes Clinical Trials
127 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 127 trials
Recruiting
Phase 4
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana90 enrolled1 locationNCT06613854
Recruiting
Phase 4
Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
Type 1 DiabetesPregnancy, High Risk
Ohio State University44 enrolled1 locationNCT07293715
Recruiting
Phase 4
Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University60 enrolled1 locationNCT07558863
Recruiting
Phase 4
Extended Oral Antibiotic Prophylaxis in Diabetic Fracture Patients
DiabetesFracture Lower LegFracture Fixation, Internal
Texas Tech University Health Sciences Center, El Paso40 enrolled3 locationsNCT07561541
Recruiting
Phase 4
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Gestational Diabetes
Maisa N. Feghali, MD13 enrolled1 locationNCT05482789
Recruiting
Phase 4
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company344 enrolled21 locationsNCT07438444
Recruiting
Phase 4
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Diabetes Mellitus, Type 2DiabetesType 2 Diabetes
Stanford University104 enrolled2 locationsNCT06657209
Recruiting
Phase 4
Tirzepatide Use in People With Obesity and Type 1 Diabetes
ObesityType1diabetes
Dasman Diabetes Institute60 enrolled1 locationNCT07096908
Recruiting
Phase 4
Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
Diabetes MellitusType 2 DM
Nabiqasim Industries (Pvt) Ltd800 enrolled2 locationsNCT06862739
Recruiting
Phase 4
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
Type 2 DiabetesSpinal Cord Injuries
Marzieh Salehi50 enrolled2 locationsNCT06706284
Recruiting
Phase 4
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
Genetic PredispositionType 2 DiabetesMetabolic Diseases
Massachusetts General Hospital125 enrolled1 locationNCT06003153
Recruiting
Phase 4
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
Diabetes Mellitus, Type 2
Novo Nordisk A/S586 enrolled75 locationsNCT07112339
Recruiting
Phase 4
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University100 enrolled1 locationNCT07272343
Recruiting
Phase 4
iGlarLixi CGM Study in Chinese T2D Individuals After OADs
Type 2 Diabetes (T2D)
Sanofi678 enrolled1 locationNCT06671587
Recruiting
Phase 4
Glycemic Variability of Combination Therapies in T2DM
Type 2 Diabetes Mellitus (T2DM)
JW Pharmaceutical178 enrolled1 locationNCT07442006
Recruiting
Phase 4
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Diabetic Foot UlcerDiabetic FootFoot Ulcer Due to Type 2 Diabetes Mellitus+4 more
Applied Biologics, LLC60 enrolled1 locationNCT07159282
Recruiting
Phase 4
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
ObesityPre-diabetes
Philip Kern96 enrolled1 locationNCT05051436
Recruiting
Phase 4
Impact GLP-1 Agonists Following Bariatric
Diabetes MellitusMetabolic SyndromeHypertension+2 more
University of Missouri-Columbia150 enrolled1 locationNCT06132477
Recruiting
Phase 4
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Type II Diabetes MellitusEfficacy, SelfSafety Issues
Getz Pharma2,000 enrolled6 locationsNCT05164263
Recruiting
Phase 4
Quantifying Hepatic Mitochondrial Fluxes in Humans
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio60 enrolled2 locationsNCT05305287